0001562180-20-005231.txt : 20200730
0001562180-20-005231.hdr.sgml : 20200730
20200730182253
ACCESSION NUMBER: 0001562180-20-005231
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200728
FILED AS OF DATE: 20200730
DATE AS OF CHANGE: 20200730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MONTECALVO DAVID A
CENTRAL INDEX KEY: 0001241973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08036
FILM NUMBER: 201060899
MAIL ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC
CENTRAL INDEX KEY: 0000105770
STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060]
IRS NUMBER: 231210010
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 6105942900
MAIL ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: WEST CO INC
DATE OF NAME CHANGE: 19990405
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-07-28
false
0000105770
WEST PHARMACEUTICAL SERVICES INC
WST
0001241973
MONTECALVO DAVID A
530 HERMAN O. WEST DRIVE
EXTON
PA
19341
false
true
false
false
SVP, Glob Ops and Supply Chain
Common Stock
2020-07-28
4
M
false
10792.00
71.79
A
15732.42
D
Common Stock
2020-07-28
4
M
false
3000.00
83.47
A
18732.42
D
Common Stock
2020-07-28
4
S
false
716.00
266.058
D
18016.42
D
Common Stock
2020-07-28
4
S
false
7773.00
264.1315
D
10243.42
D
Common Stock
2020-07-28
4
S
false
2881.00
265.1292
D
7362.42
D
Common Stock
2020-07-28
4
S
false
138.00
265.8507
D
7224.42
D
Common Stock
2020-07-28
4
S
false
3000.00
265.9769
D
4224.42
D
Common Stock
2020-07-29
4
M
false
5358.00
83.47
A
9582.42
D
Common Stock
2020-07-29
4
S
false
3273.00
270.7038
D
6309.42
D
Stock Option (Right to Buy)
71.79
2020-07-28
4
M
false
10792.00
0.00
D
2017-02-23
2026-09-26
Common Stock
10792.00
0.00
D
Stock Options (Right to buy)
83.47
2020-07-28
4
M
false
3000.00
0.00
D
2018-02-21
2027-02-21
Common Stock
3000.00
8144.00
D
Stock Options (Right to buy)
83.47
2020-07-29
4
M
false
5358.00
0.00
D
2018-02-21
2027-02-21
Common Stock
5358.00
2786.00
D
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $263.80 to $264.79, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $264.80 to $265.77, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $265.80 to $265.87, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $265.9762 to $265.9769, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
Ryan Metz as Agent for David A. Montecalvo
2020-07-29